查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1259872

嗜睡症治療藥市場佔有率·規模·趨勢·產業分析·預測 (2023年～2032年):類型 (猝倒症、無猝倒症的嗜睡症、繼發性嗜睡症)·產品·各地區

Narcolepsy Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Type (Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy); By Product; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

全球猝睡症治療藥的市場規模到2032年前將成長到77億5,000萬美元的規模。

本報告提供全球猝睡症治療藥的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球猝睡症治療藥市場洞察

  • 產業概要
  • 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • PESTEL分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19:影響分析

第5章 全球猝睡症治療藥市場:各類型

  • 主要調查結果
  • 猝倒
  • 不伴隨猝倒的猝睡症
  • 次發性猝睡症

第6章 全球猝睡症治療藥市場:各產品

  • 主要調查結果
  • 羥丁酸鈉
  • 中樞神經刺激藥
  • SSRI (選擇性血清素再回收抑制劑)
  • 三環抗憂鬱藥物

第7章 全球猝睡症治療藥市場:各地區

  • 主要調查結果
  • 北美
  • 歐洲
  • 亞太地區
  • 中東及非洲
  • 南美

第8章 競爭情形

  • 擴張·收購的分析
  • 聯盟/合作/協定/展示會

第9章 企業簡介

  • Addrenex Pharmaceuticals, Inc
  • Arena Pharmaceuticals, Inc.
  • BIOPROJET
  • Cephalon, Inc
  • Evotec AG
  • Graymark Healthcare, Inc.
  • Hypnion, Inc
  • Jazz Pharmaceuticals, Inc
  • Ligand Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM1304

The global narcolepsy therapeutics market size is expected to reach USD 7.75 billion by 2032, according to a new study by Polaris Market Research. The report "Narcolepsy Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Type (Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy); By Product; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Narcolepsy therapeutics market is driven by several factors, including increasing awareness and diagnosis of narcolepsy, the availability of effective treatments, and the development of new medications, drive market growth. Treatments for narcolepsy include stimulants to promote wakefulness, sodium oxybate to improve nighttime sleep and reduce cataplexy, and antidepressants to manage cataplexy and other symptoms.

Recent developments in the narcolepsy therapeutics market, such as the approval of new medications and formulations, the acquisition of existing drugs by companies, and the ongoing research and development of new treatments, are expected to drive market growth.

For example, the approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) and Wakix (pitolisant) by the U.S. Food and Drug Administration (FDA) in 2020, and the acquisition of Sunosi (solriamfetol) by Axsome Therapeutics Inc. in 2021, are expected to increase the availability of effective treatments for narcolepsy.

The increasing use of telemedicine and digital health technologies to improve access to healthcare and support remote monitoring and management of patients with narcolepsy is expected to further drive market growth.

Narcolepsy Therapeutics Market Report Highlights:

cataplexy segment is expected to dominate the narcolepsy therapeutics market over the forecast period due to increase in the demand for cataplexy treatment and increased prevalence of the narcolepsy.

Sodium Oxybate segment held a largest market share and will continue the dominance over the forecast period, due to a most commonly prescribed medicine for the cataplexy treatment.

North America dominates the global market due to the prevalence of the narcolepsy is highest in this region and FDA has approved several medications for the treatment of narcolepsy.

The global key market players include Addrenex Pharmaceuticals, Cephalon, Inc., Arena Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., BIOPROJET, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the Narcolepsy Therapeutics market report based on type, product, and region:

Narcolepsy Therapeutics, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Cataplexy

Narcolepsy without Cataplexy

Secondary Narcolepsy

Narcolepsy Therapeutics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Sodium Oxybate

Central Nervous System Stimulants

Selective Serotonin Reuptake Inhibitor

Tricyclic Antidepressants

Narcolepsy Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Narcolepsy Therapeutics Market Insights

  • 4.1. Narcolepsy Therapeutics Market - Industry Snapshot
  • 4.2. Narcolepsy Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing global prevalence of narcolepsy
      • 4.2.1.2. Narcolepsy awareness programs and services
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse effects and risks related to narcolepsy drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Narcolepsy Therapeutics Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Narcolepsy Therapeutics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Narcolepsy Therapeutics, by Type, 2019-2032 (USD Billion)
  • 5.3. Cataplexy
    • 5.3.1. Global Narcolepsy Therapeutics Market, by Cataplexy, by Region, 2019-2032 (USD Billion)
  • 5.4. Narcolepsy without Cataplexy
    • 5.4.1. Global Narcolepsy Therapeutics Market, by Narcolepsy without Cataplexy, by Region, 2019-2032 (USD Billion)
  • 5.5. Secondary Narcolepsy
    • 5.5.1. Global Narcolepsy Therapeutics Market, by Secondary Narcolepsy, by Region, 2019-2032 (USD Billion)

6. Global Narcolepsy Therapeutics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Sodium Oxybate
    • 6.3.1. Global Narcolepsy Therapeutics Market, by Sodium Oxybate, by Region, 2019-2032 (USD Billion)
  • 6.4. Central Nervous System Stimulants
    • 6.4.1. Global Narcolepsy Therapeutics Market, by Central Nervous System Stimulants, by Region, 2019-2032 (USD Billion)
  • 6.5. Selective Serotonin Reuptake Inhibitor
    • 6.5.1. Global Narcolepsy Therapeutics Market, by Selective Serotonin Reuptake Inhibitor, by Region, 2019-2032 (USD Billion)
  • 6.6. Tricyclic Antidepressants
    • 6.6.1. Global Narcolepsy Therapeutics Market, by Tricyclic Antidepressants, by Region, 2019-2032 (USD Billion)

7. Global Narcolepsy Therapeutics Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Narcolepsy Therapeutics Market - North America
    • 7.3.1. North America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.2. North America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Narcolepsy Therapeutics Market - U.S.
      • 7.3.3.1. U.S.: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Narcolepsy Therapeutics Market - Canada
      • 7.3.4.1. Canada: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Narcolepsy Therapeutics Market - Europe
    • 7.4.1. Europe: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Narcolepsy Therapeutics Market - UK
      • 7.4.3.1. UK: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Narcolepsy Therapeutics Market - France
      • 7.4.4.1. France: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Narcolepsy Therapeutics Market - Germany
      • 7.4.5.1. Germany: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Narcolepsy Therapeutics Market - Italy
      • 7.4.6.1. Italy: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Narcolepsy Therapeutics Market - Spain
      • 7.4.7.1. Spain: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Narcolepsy Therapeutics Market - Netherlands
      • 7.4.8.1. Netherlands: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Narcolepsy Therapeutics Market - Russia
      • 7.4.9.1. Russia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Narcolepsy Therapeutics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Narcolepsy Therapeutics Market - China
      • 7.5.3.1. China: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Narcolepsy Therapeutics Market - India
      • 7.5.4.1. India: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Narcolepsy Therapeutics Market - Malaysia
      • 7.5.5.1. Malaysia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Narcolepsy Therapeutics Market - Japan
      • 7.5.6.1. Japan: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Narcolepsy Therapeutics Market - Indonesia
      • 7.5.7.1. Indonesia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Narcolepsy Therapeutics Market - South Korea
      • 7.5.8.1. South Korea: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Narcolepsy Therapeutics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Narcolepsy Therapeutics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Narcolepsy Therapeutics Market - UAE
      • 7.6.4.1. UAE: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Narcolepsy Therapeutics Market - Israel
      • 7.6.5.1. Israel: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Narcolepsy Therapeutics Market - South Africa
      • 7.6.6.1. South Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Narcolepsy Therapeutics Market - Latin America
    • 7.7.1. Latin America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Narcolepsy Therapeutics Market - Mexico
      • 7.7.3.1. Mexico: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Narcolepsy Therapeutics Market - Brazil
      • 7.7.4.1. Brazil: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Narcolepsy Therapeutics Market - Argentina
      • 7.7.5.1. Argentina: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Addrenex Pharmaceuticals, Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Arena Pharmaceuticals, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BIOPROJET
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Cephalon, Inc
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Evotec AG
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Graymark Healthcare, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Hypnion, Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Jazz Pharmaceuticals, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Ligand Pharmaceuticals, Inc
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Teva Pharmaceutical Industries Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 U.S.: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 9 Canada: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Europe: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 UK: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 15 France: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 17 Germany: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 Italy: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 21 Spain: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Russia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 29 China: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 India: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Japan: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 39 South Korea: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 45 UAE: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 47 Israel: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 South Africa: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Latin America: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Mexico: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Brazil: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Narcolepsy Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Argentina: Narcolepsy Therapeutics Market, by Type, 2019-2032 (USD Billion)

List of Figures

Figure 1 Global Narcolepsy Therapeutics Market, 2019-2032 (USD Billion)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Product

Figure 7 Global Narcolepsy Therapeutics Market, by Product, 2022 & 2032 (USD Billion)

Figure 8 Market by Type

Figure 9 Global Narcolepsy Therapeutics Market, by Type, 2022 & 2032 (USD Billion)

Figure 10 Narcolepsy Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)

Figure 11 Strategic Analysis - Narcolepsy Therapeutics Market